Annovis Bio ANVS Stock
Annovis Bio Price Chart
Annovis Bio ANVS Financial and Trading Overview
| Annovis Bio stock price | 1.72 USD |
| Previous Close | 1.75 USD |
| Open | 1.78 USD |
| Bid | 0 USD x 520000 |
| Ask | 0 USD x 900000 |
| Day's Range | 1.73 - 1.84 USD |
| 52 Week Range | 1.54 - 5.5 USD |
| Volume | 802.37K USD |
| Avg. Volume | 1.18M USD |
| Market Cap | 75.3M USD |
| Beta (5Y Monthly) | 1.189 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.71 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.5 USD |
ANVS Valuation Measures
| Enterprise Value | 30.66M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.5258621 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.8548386 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Annovis Bio Stock Price History
| Beta (5Y Monthly) | 1.189 |
| 52-Week Change | -42.15% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 5.5 USD |
| 52 Week Low | 1.54 USD |
| 50-Day Moving Average | 1.94 USD |
| 200-Day Moving Average | 2.56 USD |
ANVS Share Statistics
| Avg. Volume (3 month) | 1.18M USD |
| Avg. Daily Volume (10-Days) | 924.05K USD |
| Shares Outstanding | 42.54M |
| Float | 25.1M |
| Short Ratio | 4.12 |
| % Held by Insiders | 14.09% |
| % Held by Institutions | 16.71% |
| Shares Short | 5.02M |
| Short % of Float | 12.95% |
| Short % of Shares Outstanding | 11.79% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -106.032% |
| Return on Equity (ttm) | -220.60% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -28854196 USD |
| Diluted EPS (ttm) | -1.71 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 19.53M USD |
| Total Cash Per Share (mrq) | 0.69 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 5.799 |
| Book Value Per Share (mrq) | 0.62 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -25619704 USD |
| Levered Free Cash Flow (ttm) | -15183042 USD |
Profile of Annovis Bio
| Country | United States |
| State | PA |
| City | Malvern |
| Address | 101 Lindenwood Drive |
| ZIP | 19355 |
| Phone | 484 875 3192 |
| Website | https://www.annovisbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 7 |
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 3 to treat alzheimer's disease, as well as in open-label phase 3 to treat parkinson's disease. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia. Annovis Bio, Inc. was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.
Q&A For Annovis Bio Stock
What is a current ANVS stock price?
Annovis Bio ANVS stock price today per share is 1.72 USD.
How to purchase Annovis Bio stock?
You can buy ANVS shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Annovis Bio?
The stock symbol or ticker of Annovis Bio is ANVS.
Which industry does the Annovis Bio company belong to?
The Annovis Bio industry is Biotechnology.
How many shares does Annovis Bio have in circulation?
The max supply of Annovis Bio shares is 42.54M.
What is Annovis Bio Price to Earnings Ratio (PE Ratio)?
Annovis Bio PE Ratio is now.
What was Annovis Bio earnings per share over the trailing 12 months (TTM)?
Annovis Bio EPS is -1.71 USD over the trailing 12 months.
Which sector does the Annovis Bio company belong to?
The Annovis Bio sector is Healthcare.
Annovis Bio ANVS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NYSE Composite Index
NYA
US
|
23475.13 USD — |
-0.51
|
— — | 23332.58 USD — | 23596.22 USD — | — - | — — |
- {{ link.label }} {{link}}